The Valley Desk

NCT02514174 · Interventional trial

Afatinib Treatment for Patients With EGFR Mutation Positive NSCLC Who Are Age 70 or Older

Overall registry status Completed

Phase 4

Conditions Carcinoma, Non-Small-Cell Lung, ErbB Receptors

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov